Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Deals
Biotech
Novartis inks $175M option deal for Sironax’s BBB tech
If Novartis decides to buy the platform, Sironax will have the chance to make up to $175 million in upfront and near-term payments.
Gabrielle Masson
Jul 9, 2025 10:29am
AstraZeneca’s Alexion pens $825M AAV capsid pact with JCR
Jul 9, 2025 4:52am
Concentra extends biotech shopping spree by collecting Cargo
Jul 8, 2025 9:28am
Rallybio shifts gears, cashing out of Recursion pact
Jul 8, 2025 8:59am
Fierce Pharma
Summit in high-stakes deal talks with AstraZeneca: Bloomberg
Jul 7, 2025 10:45am
Chugai inks $250M deal for Gero’s age-related disease targets
Jul 7, 2025 3:00am
